Embecta Corp. Common Stock (EMBC) is a publicly traded Healthcare sector company. As of May 21, 2026, EMBC trades at $3.06 with a market cap of $179.76M and a P/E ratio of 1.84. EMBC moved +5.34% today. Year to date, EMBC is -73.67%; over the trailing twelve months it is -75.10%. Its 52-week range spans $2.77 to $21.48. Analyst consensus is neutral with an average price target of $5.00. Rallies surfaces EMBC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes EMBC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $3.06 |
| Market Cap | $179.76M |
| P/E Ratio | 1.84 |
| EPS | $1.64 |
| Dividend Yield | 0.01% |
| 52-Week High | $21.48 |
| 52-Week Low | $2.77 |
| Volume | 511 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.08B |
| Net Income | $95.40M |
| Gross Margin | 62.64% |
2 analysts cover EMBC: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.00.